Beyond ALK and EGFR: Novel molecularly driven targeted therapies in NSCLC

Date 04 February 2016
Event ESMO Preceptorship on Lung Cancer Manchester 2016
Session Advanced NSCLC
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Translational Research
Presenter Federico Cappuzzo